1. Home
  2. OSRHW
  3. OSRHW News

Latest OSR Holdings Inc. Warrant (OSRHW) News on July 1, 2025

Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics
OSRHW

PR Newswire

2 months ago

Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics

Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology
OSRHW

PR Newswire

3 months ago

Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology

OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies
OSRHW

PR Newswire

3 months ago

OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies

Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma
OSRHW

PR Newswire

3 months ago

Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer
OSRHW

PR Newswire

3 months ago

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

Share on Social Networks: